Efficacy and safety of nivolumab in the treatment of non-trichoblastic adnexal carcinoma
Background: Adnexal carcinomas are rare skin cancers. In the case of non-resectable cancer, there is no consensus on management. Treatment options most often include radiotherapy and/or different chemotherapy protocols. The efficacy of anti PD1 agents has been suggested in trichoblastic carcinomas, but remains to be demonstrated in adnexal carcinomas in general.
Authors
- Aude Fléchon (ORCID: https://orcid.org/0000-0002-0129-6101)
- M. Beylot‐Barry (ORCID: https://orcid.org/0000-0001-6150-1229)
- L. Mortier
- M. Boileau
- Assia Lamrani-Ghaouti (ORCID: https://orcid.org/0000-0002-1022-0280)
- C. Lebbé
- A. Marabelle
- Thomas Jouary (ORCID: https://orcid.org/0000-0002-9080-3661)
- Sylvie Chevret (ORCID: https://orcid.org/0000-0001-6449-4730)
- Maxime Batistella
- François Goldwasser (ORCID: https://orcid.org/0000-0002-7128-6128)
- Olivier Bouché (ORCID: https://orcid.org/0000-0002-8284-3743)
- Clotilde Simon
- P. Saiag
- Esma Saada Bouzid
- Y. Kazbennaou
Institutions
- Inserm (FR)
- Institut Gustave Roussy (FR)
- Centre Hospitalier Universitaire de Bordeaux (FR)
- Centre Hospitalier Universitaire de Lille (FR)
- CHU Ambroise Paré (BE)
- Lille’s Cardiology Hospital (FR)
- Hôpital Cochin (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- Centre Hospitalier De Pau (FR)
- Centre Léon Bérard (FR)
- Centre Hospitalier Universitaire de Reims (FR)
- Hôpital Ambroise-Paré (FR)
- UniCancer Group (FR)
- Hôpital Saint-Louis (FR)
- Centre Antoine Lacassagne (FR)
- Clinique Ambroise Paré (FR)
- Onco Lille (FR)
- Bicêtre Hospital (FR)
- Carrier (United States) (US)
- Université de Reims Champagne-Ardenne (FR)
Publication Details
- Journal
- EJC Skin Cancer
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1016/j.ejcskn.2025.100677
- Primary Topic
- Cancer and Skin Lesions
- Type
- article
- Field-Weighted Citation Impact
- 0.00